Invitation to Vitrolife Group's presentation of the Q2 2025 interim report
Rhea-AI Summary
Vitrolife (VTRLY) has scheduled the release of its Q2 2025 interim report for Thursday, July 17, 2025, at 08:00 am CEST. The company will host a conference call and webcast at 10:00 am CEST on the same day.
The presentation will be conducted in English by CEO Bronwyn Brophy O'Connor and acting CFO Helena Wennerström. The event will include a report presentation followed by a Q&A session. Presentation materials will be accessible on the Vitrolife Group website before the call, and a recording will be available afterward.
Positive
- None.
Negative
- None.
The presentation will be held in English by Bronwyn Brophy O'Connor, CEO, and Helena Wennerström, acting CFO. The conference call will begin with a presentation of the report followed by a question-and-answer session. The presentation material will be available prior to the start of the conference call on the Vitrolife Group website www.vitrolifegroup.com.
To follow the webcast, please use this link.
To participate in the conference call please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.
After the event, the presentation material and a recording of the webcast will be available at www.vitrolifegroup.com.
VITROLIFE AB (publ)
Contact:
Amelie Wilson, Investor relations, external corporate communications and executive support, awilson@vitrolife.com
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Invitation to Vitrolife Group’s presentation of the Q2 2025 interim report |